Atlas Trials

Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach

Clinical trial NCT06151691 · UNKNOWN

Trial details

NCT number
NCT06151691
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2023-12-01
Primary completion
2025-09-30
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.